These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 25708048

  • 1. Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.
    Vats C, Dhanjal J, Goyal S, Gupta A, Bharadvaja N, Grover A.
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S14. PubMed ID: 25708048
    [No Abstract] [Full Text] [Related]

  • 2. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
    Doustdar F, Pazhang M, Mehrnejad F, Safarzadeh M, Rabiei D, Chaparzadeh N, Falahati H, Mir-Derikvand M.
    Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249
    [Abstract] [Full Text] [Related]

  • 3. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
    Rodrigues Vde F, Telles MA, Ribeiro MO, Cafrune PI, Rossetti ML, Zaha A.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
    [Abstract] [Full Text] [Related]

  • 4. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M, Rath SN, Sonawane A.
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [Abstract] [Full Text] [Related]

  • 5. A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.
    Aono A, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.
    J Microbiol Methods; 2018 Nov; 154():52-54. PubMed ID: 30316980
    [Abstract] [Full Text] [Related]

  • 6. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
    Shi W, Zhang X, Jiang X, Yuan H, Lee JS, Barry CE, Wang H, Zhang W, Zhang Y.
    Science; 2011 Sep 16; 333(6049):1630-2. PubMed ID: 21835980
    [Abstract] [Full Text] [Related]

  • 7. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P, Ferrer P, Gilman RH, López-Llano J, Fuentes P, Valencia E, Zimic MJ.
    Tuberculosis (Edinb); 2009 Mar 16; 89(2):109-13. PubMed ID: 19249243
    [Abstract] [Full Text] [Related]

  • 8. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M, Sheen P, Quiliano M, Gutierrez A, Gilman RH.
    Infect Genet Evol; 2010 Mar 16; 10(2):346-9. PubMed ID: 19963078
    [Abstract] [Full Text] [Related]

  • 9. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Mestdagh M, Fonteyne PA, Realini L, Rossau R, Jannes G, Mijs W, De Smet KA, Portaels F, Van den Eeckhout E.
    Antimicrob Agents Chemother; 1999 Sep 16; 43(9):2317-9. PubMed ID: 10471589
    [Abstract] [Full Text] [Related]

  • 10. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
    Rajendran V, Sethumadhavan R.
    J Biomol Struct Dyn; 2014 Sep 16; 32(2):209-21. PubMed ID: 23383724
    [Abstract] [Full Text] [Related]

  • 11. Study of pyrazinamidase structural changes in pyrazinamide resistant and susceptible isolates of Mycobacterium tuberculosis.
    Ahmady A, Poolad T, Rafee P, Tousheh M, Kahbazi M, Arjomandzadegan M.
    Tuberk Toraks; 2013 Sep 16; 61(2):110-4. PubMed ID: 23875588
    [Abstract] [Full Text] [Related]

  • 12. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.
    Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V.
    Antimicrob Agents Chemother; 1999 Jul 16; 43(7):1761-3. PubMed ID: 10390238
    [Abstract] [Full Text] [Related]

  • 13. Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis.
    Pandey B, Grover S, Tyagi C, Goyal S, Jamal S, Singh A, Kaur J, Grover A.
    Gene; 2016 Apr 25; 581(1):31-42. PubMed ID: 26784657
    [Abstract] [Full Text] [Related]

  • 14. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
    Mestdagh M, Realini L, Fonteyne PA, Rossau R, Jannes G, Mijs W, DE Smet KA, Portaels F, Van den Eeckhout E.
    Microb Drug Resist; 2000 Apr 25; 6(4):283-7. PubMed ID: 11272256
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
    Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W.
    PLoS One; 2011 Jan 24; 6(1):e15785. PubMed ID: 21283666
    [Abstract] [Full Text] [Related]

  • 16. Revelation of enzyme activity of mutant pyrazinamidases from Mycobacterium tuberculosis upon binding with various metals using quantum mechanical approach.
    Rasool N, Husssain W, Khan YD.
    Comput Biol Chem; 2019 Dec 24; 83():107108. PubMed ID: 31442707
    [Abstract] [Full Text] [Related]

  • 17. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
    Ramirez-Busby SM, Valafar F.
    Antimicrob Agents Chemother; 2015 Sep 24; 59(9):5267-77. PubMed ID: 26077261
    [Abstract] [Full Text] [Related]

  • 18. The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD.
    Sun Q, Li X, Perez LM, Shi W, Zhang Y, Sacchettini JC.
    Nat Commun; 2020 Jan 17; 11(1):339. PubMed ID: 31953389
    [Abstract] [Full Text] [Related]

  • 19. Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.
    Mustazzolu A, Iacobino A, Giannoni F, Piersimoni C, Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group, Fattorini L.
    J Clin Microbiol; 2017 Dec 17; 55(12):3552-3553. PubMed ID: 28904184
    [No Abstract] [Full Text] [Related]

  • 20. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C, Yamane N, Yogesh B, Ano H, Takashima T.
    Diagn Microbiol Infect Dis; 2004 Feb 17; 48(2):111-6. PubMed ID: 14972380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.